Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Tried to buy 2 grands worth on ii earlier and same there Ohmni.
Let's hope its an early sign for what will hopefully be a good week with TRX and get us back over .70 for starters.
ATB
Cannot buy 100 quids worth on Halifax this morning. NT to buy.
Let's hope we get a nice lift leading into Tuesday's NHS bill announcement.
There's a nice ascending triangle appearing on the intraday chart.
Bodes well for next week.
GLALTHs
Why anyone would participate in an auction to sell below what you could get on the open market is beyond me.
MM games.....
Are we going to see another "representative" UT trade @ 0.61?
If Jber wasn't so efficient a MM we would be at the 50sma 0.68 by now.
Watch any stop losses...
GLA
Tissue damage repaired by TRX tech. is nothing short of a marvel.
A welcoming and large market for this innovative proven product will do well.
Revised leadership team robust too.
GLA
Blimey Naise, you did go through the mill with that one! Hope you're fighting fit now!
Good day for TRX today, managed a small rise but lost it right at the end. Although looking at the action in today's market especially across the pond that counts as a success!
Richard08 I don't think so many appreciate the problem with chronic wounds until you get one. Years ago I had a small graze on my shin that I ignore and it got infected with MRSA . The bit of wood I thought I had embedded in the wound and tried to get out was actually my exposed bone. It took months and months of medical treatment to get better and it left a scar many times bigger than the graze. I keep a good first aid kit now
https://m.youtube.com/watch?v=VURo1glkV50
Hi ibuystocksdie, the above link takes you to the most recent presentation from the CEO and CFO. O go back to your initial question I was fortunate enough to come across TRX last year and remember asking all the same questions as yourself. My initial look at the sp over time and current price (about 0.5p at the time) nearly put me off looking any further as it seemed like just another biotech that was clinging on by the skin of it's teeth. But there is a turn around story and a huge opportunity in a re-opening play here. Now the company is on a much more secure footing, led by a new board determined to commercialise their current products. They have spent the last year cutting costs and spending money on expansion plans. The impression that comes through the video on the above link is that they are poised for when covid is over and elective surgery resumes. Good luck and hope you join us! The general feeling on this board is that we are genuinely through the worst now and the future is bright!
https://www.hardmanandco.com/wp-content/uploads/2020/10/TRX-post-interims-update-–-7-Oct-2020.pdf
From October last year, worth reading.
Thanks both - the annual report is impressive and I can't see any reason not to invest. It really seems like an innovative company that should be attracting far more interest.
I can't understand why this isn't attracting more attention. The reason behind the share decline seems to be explained well enough, and doesn't seem terminal in a five year outlook.
It all seems very positive!
Ibuystocksdie
Have you read any of the Annual Reports or Presenations... you will probably gain form checking them if you havent so far
https://www.tissueregenix.com/investors/results-reports-and-presentations/
There are a lot of shares in issue. Some of the holders taking profit from the extreme lows. £40m cap covers a lot - cash (£8-9m), inventory (£7m), FDA and CE approved products, revenue at £13m, infrastructure upgrade and potential to take that to £30m at phase 2 completion, white label product with J&J (rumoured but visible in videos of marketing), two new products to be launched this year (per CEO discussion on Wednesday). Elective surgeries will go through the roof - lots of people need operations so will be huge demand for their products. Do your own research !! But very little downside and major upside potential is my take. I write more in my Twitter feed @mbingo. Chairman bought a few in Jan/Feb. Hope the new CEO will buy too. Lombard Odier added a few more too.
Thanks. That explains some of the downturn - I was aware of the Woodford collapse, but had not appreciated the damage it had done to specific companies.
I note your previous comments about reduction of loss from 7 to 3 million, which is good going at this time.
This doesn't smell like a dead-end company, but I'll need to find out more about the USA plans you refer to.
On the face of it, it seems like this should recover nicely in a few years. I'll do some more digging on the American stuff! Thanks
a very brief surmise.
TRX have innovative products and they are already in circulation.
A large fund (Woodford) held a majority of stock and went bust.... which dropped share price drastically as they had to sell.
The Chief Financial Officer at the time organised a massive loan at very high interest rates that nobody on the board liked. He was replaced.
They then decided to do a placing at a ridiculous cost reduction that has never been explained. This diluted long term holders and the share base by alot.
Various things have happened. CE mark for certain products, white label agreements etc.
Change of management and Covid then hit and we are about 12-18 months from breaking even and making profit.
Expansion already on the way in USA phase one complete which should take us to profit. Phase 2 adds extra manufacturing income.
Very brief run down since I have been invested at 11p per share....
I'm still here..... says something.
Hi. I wonder if anyone would mind helping me understand more about Tissue Regenix?
Reading through their website, it sounds like they're offering genuinely innovative technology. Am I correct in thinking that none of the allografts have reached the market yet?
The share price has tumbled over an extended period - why is this? Was there a lot of initial interest, but the SP dropped as coming to market has been delayed? Or is there another cause?
The website lists "goals for 2019". Has medical attention being focused on covid destroyed their recent year, or is the company stagnant now?
I'm interested to know why the share price has tumbled over such a period, and what hope there might be of recovery.
The premise of the research sounds fantastic. Why isn't this thing through the roof?